Ipca Laboratories Q4FY26 Result Update: Margin Expansion Supports Strong Profit Growth
Ipca Laboratories Q4FY26 Result Update: Margin Expansion Supports Strong Profit Growth Introduction Ipca Laboratories concluded FY26 with improved financial performance, supported by steady domestic formulations demand, stronger export generics sales and better operating margins. In Q4FY26, consolidated revenue from operations … Continue reading Ipca Laboratories Q4FY26 Result Update: Margin Expansion Supports Strong Profit Growth
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed